NASDAQ:PRE Prenetics Global (PRE) Stock Price, News & Analysis $8.04 +0.13 (+1.58%) Closing price 07/3/2025 01:25 PM EasternExtended Trading$8.10 +0.06 (+0.81%) As of 07/3/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Prenetics Global Stock (NASDAQ:PRE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Prenetics Global alerts:Sign Up Key Stats Today's Range$7.84▼$8.5250-Day Range$5.20▼$11.2352-Week Range$3.09▼$11.99Volume30,767 shsAverage Volume22,494 shsMarket Capitalization$98.03 millionP/E RatioN/ADividend YieldN/APrice Target$9.00Consensus RatingBuy Company Overview Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. Read More Prenetics Global Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScorePRE MarketRank™: Prenetics Global scored higher than 33% of companies evaluated by MarketBeat, and ranked 746th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingPrenetics Global has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragePrenetics Global has received no research coverage in the past 90 days.Read more about Prenetics Global's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Prenetics Global are expected to grow in the coming year, from ($3.30) to ($2.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Prenetics Global is -2.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Prenetics Global is -2.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrenetics Global has a P/B Ratio of 0.57. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.38% of the float of Prenetics Global has been sold short.Short Interest Ratio / Days to CoverPrenetics Global has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Prenetics Global has recently decreased by 4.64%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrenetics Global does not currently pay a dividend.Dividend GrowthPrenetics Global does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.38% of the float of Prenetics Global has been sold short.Short Interest Ratio / Days to CoverPrenetics Global has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Prenetics Global has recently decreased by 4.64%, indicating that investor sentiment is improving. News and Social Media1.0 / 5News Sentiment-0.23 News SentimentPrenetics Global has a news sentiment score of -0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Prenetics Global this week, compared to 1 article on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Prenetics Global insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.80% of the stock of Prenetics Global is held by insiders.Percentage Held by InstitutionsOnly 25.01% of the stock of Prenetics Global is held by institutions.Read more about Prenetics Global's insider trading history. Receive PRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter. Email Address PRE Stock News HeadlinesPrenetics Global Limited (PRE) - Yahoo FinanceJune 30, 2025 | finance.yahoo.comAryna Sabalenka Adds Her Muscle to IM8 as Ambassador & ShareholderJune 30, 2025 | msn.comTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design. July 5 at 2:00 AM | Crypto 101 Media (Ad)Aryna Sabalenka Becomes First Current Athlete Shareholder in Prenetics' IM8 Supplements BrandJune 26, 2025 | quiverquant.comQWorld No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and ShareholderJune 26, 2025 | globenewswire.comCardone Capital goes all-in on Bitcoin adding 1K BTC to its reserveJune 23, 2025 | msn.comPrenetics Global (NASDAQ:PRE) Stock, Short Interest ReportJune 19, 2025 | benzinga.comPrenetics Global First Quarter 2025 Earnings: Revenues Beat Expectations, EPS In LineJune 19, 2025 | finance.yahoo.comSee More Headlines PRE Stock Analysis - Frequently Asked Questions How have PRE shares performed this year? Prenetics Global's stock was trading at $5.80 at the start of the year. Since then, PRE shares have increased by 38.5% and is now trading at $8.0350. How were Prenetics Global's earnings last quarter? Prenetics Global Limited (NASDAQ:PRE) issued its quarterly earnings data on Thursday, June, 12th. The company reported ($0.80) EPS for the quarter. The firm earned $17.31 million during the quarter. Prenetics Global had a negative net margin of 115.91% and a negative trailing twelve-month return on equity of 28.07%. When did Prenetics Global's stock split? Shares of Prenetics Global reverse split before market open on Tuesday, November 14th 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, November 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Prenetics Global? Shares of PRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Prenetics Global own? Based on aggregate information from My MarketBeat watchlists, some other companies that Prenetics Global investors own include Arista Networks (ANET), Adobe (ADBE), Broadcom (AVGO), NVIDIA (NVDA), Intuit (INTU), Arch Capital Group (ACGL) and Celestica (CLS). Company Calendar Last Earnings6/12/2025Today7/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:PRE CIK1876431 Webwww.prenetics.com Phone852-2210-9588FaxN/AEmployees1Year FoundedN/APrice Target and Rating Average Stock Price Target$9.00 High Stock Price Target$9.00 Low Stock Price Target$9.00 Potential Upside/Downside+12.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($3.99) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$46.30 million Net Margins-115.91% Pretax Margin-143.22% Return on Equity-28.07% Return on Assets-22.27% Debt Debt-to-Equity RatioN/A Current Ratio2.07 Quick Ratio1.89 Sales & Book Value Annual Sales$30.62 million Price / Sales3.20 Cash FlowN/A Price / Cash FlowN/A Book Value$14.04 per share Price / Book0.57Miscellaneous Outstanding Shares12,200,000Free Float11,253,000Market Cap$98.03 million OptionableNot Optionable Beta0.15 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:PRE) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prenetics Global Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prenetics Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.